Sign in

CIK 0001936258

  • Large accelerated filer

NewAmsterdam Pharma Co N.V.

Sign in to watch
Ticker
NAMS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Netherlands
Entity type
Operating
Phone
35 206 2971
Business address
GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
Former names
NewAmsterdam Pharma Co B.V.

Securities

  • NAMS Ordinary Shares Nasdaq
  • NAMSW Warrant Nasdaq
  1. 4 Open-market buy Director bought 8,584 shares at $19.50 ($167,381)
  2. 4 Grant or award See Remarks acquired 55,000 shares (grant or award)
  3. 4 Option exercise Director acquired 68 shares (option exercise)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale Chief Operating Officer sold 100,000 shares
  6. 4 Derivatives Options or other derivatives
  7. 4 Option exercise Director acquired 69 shares (option exercise)
  8. 4 Option exercise Director acquired 69 shares (option exercise)
  9. 4 Planned sale Chief Operating Officer sold 100,000 shares
  10. 4 Grant or award Director acquired 10,860 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Director bought 1,135 shares at $22.49 ($25,521)
  13. 4 Option exercise Chief Accounting Officer acquired 8,269 shares (option exercise)
  14. 4 Option exercise Director acquired 3,102 shares (option exercise)
  15. 4 Grant or award Chief Scientific Officer acquired 19,302 shares (grant or award)
  16. 4 Open-market sale Chief Operating Officer sold 16,539 shares
  17. 4 Open-market sale Chief Executive Officer sold 12,258 shares
  18. 4 Option exercise Chief Scientific Officer acquired 150,000 shares (option exercise)
  19. 4 Planned sale Chief Operating Officer sold 100,000 shares
  20. 4 Open-market buy Director bought 4,005 shares at $21.02 ($84,203)

Page 3 of 7 · 132 filings